江苏省扬州地区确诊新型冠状病毒肺炎患者的中西医结合临床诊治和效果评价

朱淼, 吕清泉, 顾明华, 陈永昶, 王靖, 黄自强, 焦虹霞, 朱红, 林华

朱淼, 吕清泉, 顾明华, 陈永昶, 王靖, 黄自强, 焦虹霞, 朱红, 林华. 江苏省扬州地区确诊新型冠状病毒肺炎患者的中西医结合临床诊治和效果评价[J]. 实用临床医药杂志, 2020, 24(5): 1-5. DOI: 10.7619/jcmp.202005001
引用本文: 朱淼, 吕清泉, 顾明华, 陈永昶, 王靖, 黄自强, 焦虹霞, 朱红, 林华. 江苏省扬州地区确诊新型冠状病毒肺炎患者的中西医结合临床诊治和效果评价[J]. 实用临床医药杂志, 2020, 24(5): 1-5. DOI: 10.7619/jcmp.202005001
ZHU Miao, LYU Qingquan, GU Minghua, CHEN Yongchang, WANG Jing, HUANG Ziqiang, JIAO Hongxia, ZHU Hong, LIN Hua. Clinical diagnosis and integrated treatment of traditional Chinese and western medicine for confirmed patients with coronavirus disease 2019 in Yangzhou area of Jiangsu Province[J]. Journal of Clinical Medicine in Practice, 2020, 24(5): 1-5. DOI: 10.7619/jcmp.202005001
Citation: ZHU Miao, LYU Qingquan, GU Minghua, CHEN Yongchang, WANG Jing, HUANG Ziqiang, JIAO Hongxia, ZHU Hong, LIN Hua. Clinical diagnosis and integrated treatment of traditional Chinese and western medicine for confirmed patients with coronavirus disease 2019 in Yangzhou area of Jiangsu Province[J]. Journal of Clinical Medicine in Practice, 2020, 24(5): 1-5. DOI: 10.7619/jcmp.202005001

江苏省扬州地区确诊新型冠状病毒肺炎患者的中西医结合临床诊治和效果评价

详细信息
    通讯作者:

    林华,E-mail:Lh1391213@163.com

  • 中图分类号: R563.1

Clinical diagnosis and integrated treatment of traditional Chinese and western medicine for confirmed patients with coronavirus disease 2019 in Yangzhou area of Jiangsu Province

  • 摘要: 目的 总结和评价扬州地区新型冠状病毒肺炎(COVID-19)流行病学特征、临床症状、实验室检查结果、治疗方案及预后。 方法 收集扬州市传染病医院收治的23例COVID-19住院患者的诊治资料。 结果 (1) 病例特征: 23例患者咽拭子核酸检测阳性,其中重型1例,普通型22例; 患者年龄23~72岁,男10例,女13例; 有接触史21例(91.3%), 其中7例为家族性聚集发病; 疾病平均潜伏期5 d。(2) 临床症状: 主要表现为咳嗽、发热(78.3%), 其次为咳痰症状(26.1%)、胸闷气喘(26.1%)、消化道症状(8.7%)。(3) 血液学检查: COVID-19患者白细胞总数正常,16例入院时伴淋巴细胞降低, 2例肝功能异常; 患者出院时甘油三酯及胆固醇升高, C反应蛋白降低。(4) 影像学检查: 胸部CT显示胸膜下分布多发磨玻璃影,伴有间质增厚。(5) 治疗方案: 所有患者均给予抗病毒、抗感染、吸氧等治疗,仅1例重型患者给予无创呼吸机通气治疗,全部患者核酸检测转阴后出院。 结论 核酸检测阳性和胸部CT多发磨玻璃影、伴间质增厚是诊断COVID-19的重要依据。易感人群接触史、咳嗽发热症状、淋巴细胞低下是COVID-19感染的重要临床表现。中西药结合治疗是COVID-19的有效治疗方案。
    Abstract: Objective To summarize and evaluate the epidemiological characteristics, clinical symptoms, laboratory tests, treatment options and prognosis of novel coronavirus pneumonia(Coronavirus Disease 2019, COVID-19)in Yangzhou. Methods The clinical data of 23 COVID-19 hospitalized patients in Yangzhou Infectious Disease Hospital were collected and analyzed. Results (1) Case characteristics: nucleic acid tests(oropharyngeal swabs)were positive in 23 patients, including 1 severe case and 22 common cases, aged 23 to 72 years, with 10 males and 13 females. There were 21 cases(91.3%)with contact history, among which familial clustering occurred in 7 cases. The average incubation period was 5 days. (2) Clinical symptoms mainly included cough, fever(78.3%), followed by sputum symptoms(26.1%), chest tightness and asthma(26.1%), and digestive tract symptoms(8.7%). (3) Hematological examination: the total number of white blood cells was normal, with low lymphocytes occurring in 16 patients, abnormal liver function in two patients at admission; - triglycerides and cholesterol increased, and C reactive protein(CRP)decreased at discharge. (4) Imaging examinations: CT scan of the chest showed that multiple ground glass shadows was seen under the pleura, complicating with interstitial thickening. (5) Treatments: all the patients were treated by antiviral, anti-infective, and oxygen inhalation treatments. Only one severe patient was given non-invasive ventilation. All patients were discharged after negative results of the nucleic acid test. Conclusions Positive nucleic acid test and multiple ground-glass shadows complicating with interstitial thickening by chest CT are important evidence for diagnosis of novel coronary pneumonia, and contact history of susceptible people, cough as well as fever symptoms, and low lymphocytes are important clinical manifestations of novel coronavirus pneumonia. In clinic, comprehensive treatment of Chinese and western medicine is an effective treatment for COVID-19.
  • 中华人民共和国国家卫生健康委员会. 关于印发新型冠状病毒肺炎诊疗方案(试行第七版)的通知[EB/OL]. http: //www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a   7dfe4cef80dc7f5912eb1989.shtml.

    Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus(2019-nCoV)in Wuhan[J/OL]. J Med Virol, 2020, 92(4), 441-447.

    Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020, 395(10223): 507-513.

    闵瑞, 刘洁, 徐焱成, 等. 新型冠状病毒肺炎发病机制及临床研究进展[J/OL]. 中华医院感染学杂志. http: //kns.cnki.net/kcms/detail/11.3456.R.20200304.1653.002.html.
    中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145-151.

    Song Z, Xu Y, Bao L, et al. From SARS to MERS, thrusting coronaviruses into the spotlight[J]. Viruses, 2019, 11(1): 59-86.

    Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2(ACE2)in SARS coronavirus-induced lung injury[J]. Nature Medicine, 2005, 11(8): 875-879.

    Zou X, Chen K, Zou J W, et al. The single-cell RNA-seqdata analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to Wuhan 2019-nCoV infection[J/OL]. Frontiers of Medicine. http: //journal.hep.com.cn/fmd/EN/10.1007/s11684-020-0754-0.

    施斌斌, 傅剑雄, 孙骏. 等. 扬州地区23例新型冠状病毒肺炎患者的CT影像分析[J]. 实用临床医药杂志, 2020, 24(4): 10-12.
    王玉光, 齐文升, 马家驹, 等. 新型冠状病毒(2019-nCoV)肺炎中医临床特征与辨证治疗初探[J/OL]. 中医杂志. https: //kns.cnki.net/KCMS/detail/11.2166.R.20200129.   1258.002.html.
    李天志, 徐国纲. 新型冠状病毒肺炎诊治研究进展[EB/OL]. http: //kns. cnki. net/kcms/detail/11.1056.R.20200306.1432.002.html.
  • 期刊类型引用(3)

    1. 朱淼,张晶,耿平,王靖,刘延庆,曹柳兆,李田田,孙梅. 江苏省扬州市德尔塔毒株新型冠状病毒肺炎患者早期临床特征分析. 实用临床医药杂志. 2021(23): 4-8 . 本站查看
    2. 刘清,景阳,潘岁月,黄咏可,施宇佳,孙志琴. 28例新型冠状病毒肺炎患者的早期康复护理. 实用临床医药杂志. 2020(11): 125-128 . 本站查看
    3. 陈晶晶,张念志,韩明向,周静,陈炜,董梅,刘玲,胡蝶,李允栋,朱笑笑,李晶,汪诗清. 基于六经辨证理论浅析新型冠状病毒肺炎的治疗. 云南中医学院学报. 2020(03): 24-28 . 百度学术

    其他类型引用(0)

计量
  • 文章访问数:  406
  • HTML全文浏览量:  111
  • PDF下载量:  10
  • 被引次数: 3
出版历程
  • 收稿日期:  2020-03-11
  • 网络出版日期:  2020-08-26

目录

    /

    返回文章
    返回